The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). Acute HPV comes on quickly and resolves promptly. Chronic HBV is a long-term infection, lasting for at least 6 months. The ...

Bepirovirsen achieved functional cures in about 1 in 5 patients in global trials; FDA review is set for Oct. 26, 2026.

In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

For some people, their immune system can clear the hepatitis B virus with natural immunity. However, some individuals can build immunity to hepatitis B through vaccination. For some people, the ...

Hepatitis is a medical condition defined by inflammation of the liver. It can be caused by infection of the liver by hepatitis viruses (hepatitis B, hepatitis C and viral hepatitis) or is of unknown ...

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of ...

If someone presents you with a hepatitis B declination form, you might have some questions about it and the hepatitis B vaccine more generally. Hepatitis B is an infection of the liver due to the ...

The hepatitis B titer test can reveal whether you’re immune to the virus, either because of vaccination or previous exposure. It requires a simple blood draw. Titer tests measure antibodies in your ...

A federal vaccine advisory panel voted on Friday morning to change the longstanding recommendation that all newborns receive a dose of the hepatitis B vaccine. The federal Advisory Committee on ...

In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...